Form 4 holding
Director
Lyell Immunopharma, Inc.
- Security class
- Common Stock
- Shares / value
- 148,391
- Estimated value
- $2,976,723
- Report date
- 10 Jun 2026
- Price
- $20.06
- Ownership
- Direct
Richard Klausner - Director at Lyell Immunopharma, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- LYEL on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Richard Klausner since 05 Sep 2025
Reported holdings for Richard Klausner in Lyell Immunopharma, Inc.
Form 4 holding
Director
Lyell Immunopharma, Inc.
- Security class
- Common Stock
- Shares / value
- 42,166
- Estimated value
- $845,849
- Report date
- 10 Jun 2026
- Price
- $20.06
- Ownership
- Grantor and Trustee
Form 4 holding
Director
Lyell Immunopharma, Inc.
- Security class
- Option (right to buy)
- Shares / value
- 130,000
- Estimated value
- Report date
- 14 Jun 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Lyell Immunopharma, Inc.
- Security class
- Option (right to buy)
- Shares / value
- 9,250
- Estimated value
- Report date
- 10 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Richard Klausner in Lyell Immunopharma, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.